Decreasing Avoidable Vision Loss: Identifying Antecedents of Adherence

Alan R Morse,1,2 William H Seiple1,3 1Lighthouse Guild, New York, NY, USA; 2Harkness Eye Institute, Columbia University, New York, NY, USA; 3Department of Ophthalmology, New York University School of Medicine, New York, NY, USACorrespondence: Alan R Morse; William H SeipleLighthouse Guild, 250 West...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Morse AR, Seiple WH
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/076c5995352d4e9985968633bac48b8f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Alan R Morse,1,2 William H Seiple1,3 1Lighthouse Guild, New York, NY, USA; 2Harkness Eye Institute, Columbia University, New York, NY, USA; 3Department of Ophthalmology, New York University School of Medicine, New York, NY, USACorrespondence: Alan R Morse; William H SeipleLighthouse Guild, 250 West 64th Street, New York, NY 10023, USATel +1 212 769 6215Email armorse@lighthouseguild.org; Wseiple@lighthouseguild.orgAbstract: Adherence to medication treatment protocols and active participation by individuals in their medical care are important for all patients, but especially for those with chronic conditions such as vision loss. Adherence is crucial for decreasing avoidable vision loss. Failure to take medications as prescribed and keep scheduled appointments reduces treatment effectiveness, increases complications and results in poorer outcomes. Reasons for nonadherence vary by diagnosis and include not understanding the importance of adherence, low health literacy, lack of adequate self-efficacy, low level of activation and behavioral issues including depression. Patients may lack information about their condition and its prognosis, available treatment alternatives, and other essential information such as how to monitor their eye condition, what to do if vision deteriorates and how to get needed community-based help. Each of these factors impedes patients’ ability to engage with their physician and participate in their own care. The ability of individuals with vision loss to actively and effectively manage their health care, ie, activation, has been understudied. When patients are involved with their own care, their care experience, and most importantly, their outcomes, are improved. Identifying antecedents of adherence may help provide disease- and patient-specific pathways to reduce avoidable vision loss.Keywords: avoidable vision loss, adherence, activation, engagement, patient activation, patient engagement, AMD, diabetic eye disease, glaucoma